# Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection

> **NCT06620627** · — · RECRUITING · sponsor: **Natera, Inc.** · enrollment: 5000 (estimated)

## Conditions studied

- Colorectal Cancer Screening

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06620627
- **Lead sponsor:** Natera, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-26
- **Primary completion:** 2025-07-31
- **Final completion:** 2025-10-31
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2025-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06620627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06620627, "Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06620627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*